After observing that RA patients, particularly those bearing the CC-genotype of the IL-32 SNP promoter, produce more pro-inflammatory cytokines, we thought to investigate whether this could have an impact on disease activity of these RA patients. This evidence concerns the gene IL32 and rheumatoid arthritis.